Randomized, double-blind, placebo-controlled trial to examine the safety, pharmacokinetics and effects of Epimedium prenylflavonoids, on bone specific alkaline phosphatase and the osteoclast adaptor protein TRAF6 in post-menopausal women

Randomized, double-blind, placebo-controlled trial to examine the safety, pharmacokinetics and effects of Epimedium prenylflavonoids, on bone specific alkaline phosphatase and the osteoclast adaptor protein TRAF6 in post-menopausal women

10.1016/j.phymed.2021.153680

Saved in:

Bibliographic Details
Main Authors:	Yong, E.L., Cheong W.-F., Huang, Zhongwei, WIN PA PA THU, ANGELICA, AMAURY CAZENAVE GASSIOT, KOK YONG SENG, LOGAN SUSAN JANE SINCLAIR
Other Authors:	BIOCHEMISTRY
Format:	Article
Language:	English
Published:	ELSEVIER GMBH 2021
Subjects:	Science & Technology Life Sciences & Biomedicine Plant Sciences Chemistry, Medicinal Integrative & Complementary Medicine Pharmacology & Pharmacy Epimedium Postmenopausal women Safety Pharmacokinetics Bone turnover markers TRAF6 BIOCHEMICAL MARKERS HERBA-EPIMEDII OSTEOPOROSIS FLAVONOIDS TURNOVER PROLIFERATION ADIPOGENESIS METABOLISM GUIDELINES ICARIIN
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/205952
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

Description
Summary:	10.1016/j.phymed.2021.153680